{"filing":{"accession_number":"0001171843-26-004098","cik":"0001729214","ticker":"XRTX","company_name":"XORTX Therapeutics Inc.","form":"6-K","filing_date":"2026-06-12","report_date":null,"primary_document":"f6k_061226.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1729214/000117184326004098/f6k_061226.htm"},"events":[{"id":12137,"run_id":10702,"accession_number":"0001171843-26-004098","anchor_item_number":"EX-99.1","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"XORTX announces a voluntary election to delist its common shares from the TSX Venture Exchange (TSXV), effective immediately upon Board approval. While this is a voluntary delisting (not a forced delisting due to non-compliance), it represents a material change in the registrant's listing status and trading accessibility for shareholders. The company will maintain its Nasdaq listing, but the removal of the TSXV dual listing affects the total mix of information available to investors regarding trading venues and regulatory obligations. This falls squarely within the delisting_risk taxonomy as a notice of delisting or transfer of listing (Item 3.01 equivalent).","company_name":"XORTX Therapeutics Inc.","ticker":"XRTX","filing_date":"2026-06-12","form":"6-K","submitted_at":null,"items":[{"id":8916,"accession_number":"0001171843-26-004098","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"XORTX announces a voluntary election to delist its common shares from the TSX Venture Exchange (TSXV), effective immediately upon Board approval. While this is a voluntary delisting (not a forced delisting due to non-compliance), it represents a material change in the registrant's listing status and trading accessibility for shareholders. The company will maintain its Nasdaq listing, but the removal of the TSXV dual listing affects the total mix of information available to investors regarding trading venues and regulatory obligations. This falls squarely within the delisting_risk taxonomy as a notice of delisting or transfer of listing (Item 3.01 equivalent).","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:18:40.651146+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8916,"accession_number":"0001171843-26-004098","item_number":"EX-99.1","item_title":"exh_991.htm","event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"XORTX announces a voluntary election to delist its common shares from the TSX Venture Exchange (TSXV), effective immediately upon Board approval. While this is a voluntary delisting (not a forced delisting due to non-compliance), it represents a material change in the registrant's listing status and trading accessibility for shareholders. The company will maintain its Nasdaq listing, but the removal of the TSXV dual listing affects the total mix of information available to investors regarding trading venues and regulatory obligations. This falls squarely within the delisting_risk taxonomy as a notice of delisting or transfer of listing (Item 3.01 equivalent).","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:18:40.651146+00:00","company_name":"XORTX Therapeutics Inc.","ticker":"XRTX","filing_date":"2026-06-12"}]}